Please check your internet connection and try again.
# Montelukast/Levocetirizine
## Overview
Montelukast/levocetirizine is a combination medication used for the treatment of allergic rhinitis and chronic idiopathic urticaria. Montelukast is a leukotriene receptor antagonist, and levocetirizine is a second-generation H1 antihistamine.
## Primary Indications
* Allergic Rhinitis (seasonal and perennial)
* Chronic Idiopathic Urticaria
## Adult Dosing
The standard dose is montelukast 10 mg plus levocetirizine 5 mg orally once daily.
## Pediatric Dosing
Dosing in pediatric patients depends on age and formulation. Consult specific product labeling for approved age ranges and corresponding doses. For example:
* **Ages 6 to 11 years:** Montelukast 5 mg plus levocetirizine 2.5 mg orally once daily.
* **Ages 6 months to 5 years:** Dosing varies by age and weight, and may involve separate formulations of montelukast and levocetirizine. Refer to specific product guidelines.
## Dose Adjustments
No dose adjustment is typically required for renal or hepatic impairment specifically for the combination product. However, individual drug monographs should be consulted for guidance on dose adjustments of montelukast and levocetirizine separately if needed, particularly in severe renal impairment for levocetirizine.
## Contraindications
* Hypersensitivity to montelukast, levocetirizine, or any component of the formulation.
* Patients with phenylketonuria (due to aspartame in chewable tablets).
## Adverse Effects
* **Common:** Somnolence, fatigue, dry mouth, headache, abdominal pain, diarrhea.
* **Less Common but Serious:** Neuropsychiatric events (e.g., depression, suicidal ideation, anxiety, behavioral changes) associated with montelukast; hypersensitivity reactions.
## Key Drug Interactions
* **CNS Depressants (e.g., sedatives, tranquilizers, opioids):** Increased risk of sedation with levocetirizine.
* **Theophylline:** Montelukast may decrease theophylline serum concentrations; monitor theophylline levels.
* **CYP1A2 Inhibitors:** May increase montelukast exposure.
## Monitoring
* Monitor for neuropsychiatric adverse effects, especially changes in mood, behavior, or sleep.
* Assess for therapeutic effectiveness in symptom control.
* Monitor for signs of hypersensitivity reactions.
## Clinical Pearls
* This combination provides dual mechanisms of action for allergic rhinitis symptoms.
* Administer montelukast in the evening, regardless of mealtime. Levocetirizine can be taken in the evening or as needed; evening dosing may minimize daytime somnolence.
* The U.S. Boxed Warning for montelukast highlights the risk of serious neuropsychiatric events. Counsel patients and caregivers on these potential risks.
* Chewable tablets contain aspartame and are not suitable for patients with phenylketonuria.
---
***Disclaimer:** This information is intended for healthcare professionals and does not replace individual clinical judgment. Always consult the most current prescribing information and relevant guidelines before making any treatment decisions. Dosing and recommendations may vary based on local protocols and specific patient factors.*
